Gore today announced US Food and Drug Administration (FDA) approval of an expanded indication for the company's Viabahn VBX ...

Frank Veith, chairman of the VEITHsymposium, has announced that Gustavo Oderich will be assuming the role of the organisation ...

Endovascular Engineering (E2) has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for ...

PE randomised controlled trial (RCT) demonstrated a significant correlation between real-world, daily step-based activity as ...

Gore announced today the first patient enrolment in the IBE Plus pivotal study, a clinical trial evaluating the ...

Among patients with femoropopliteal artery disease and no tissue loss, angioplasty with the MagicTouch PTA sirolimus-coated balloon (Concept Medical) was associated with a lower one-year rate of ...

Inquis Medical has announced the US commercial launch of its latest Aventus catheter, which is designed to provide physicians ...

Surmodics has announced that it has acquired the business of Alta Biomed, a medical device coating and testing services ...

Investigators presented a new interim analysis of 1,000 prospective patients from the STRIKE-PE trial, looking at one-year ...

Charing Cross (CX) Symposium co-chair Andrew Holden (Auckland City Hospital, Auckland, New Zealand) received the VIVA Foundation’s 2026 LIVE Award yesterday morning.

As the goals of space exploration expand ever further afield, Dora Babocs (Mayo Clinic, Rochester, USA) speaks to Vascular ...

Innova Vascular has announced positive results from the pivotal TRUST study, which evaluated the Laguna thrombectomy ...